Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF

Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF

Background Little is known about the impact of chronic obstructive pulmonary disease (COPD) in patients with heart failure with preserved ejection fraction (HFpEF). Methods and Results We examined outcomes in patients with heart failure with preserved ejection fraction, according to COPD status, in...

Full description

Bibliographic Details
Main Authors: Leanne Mooney, Nathaniel M. Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay S. Desai, Jean L. Rouleau, Masatoshi Minamisawa, Amil M. Shah, Martin P. Lefkowitz, Michael R. Zile, Dirk J. Van Veldhuisen, Marc A. Pfeffer, Inder S. Anand, Aldo P. Maggioni, Michele Senni, Brian L. Claggett, Scott D. Solomon, John J. V. McMurray
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
chronic obstructive pulmonary disease
heart failure with preserved ejection fraction
right ventricle
sacubitril/valsartan
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.021494

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.021494

Similar Items